The authors of a study that undertook a reanalysis of Pfizer and Moderna’s clinical trial data have written an open letter in The British Medical Journal to the CEOs of both corporations, urging them to release all patient clinical data from COVID-19 vaccine clinical trials.
The study in question combined data from both vaccine clinical trials, given that their respective products utilise the same new mRNA technology.
Findings from the study strongly suggest what many amongst the vaccine-injured community have been saying for a long time — that the incidence of serious adverse events is not rare nor very rare, but rather more common than has been officially acknowledged.
The study, published in the scientific journal Vaccine, can be found online: doi:10.1016/j.vaccine.2022.08.036
